mefloquine has been researched along with losartan potassium in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Nightingale, SL | 1 |
Burgmann, H; Chullawichit, S; Daxböck, F; El-Menyawi, I; Graninger, W; Looareesuwan, S; Stoiser, B; Thalhammer, F | 1 |
1 trial(s) available for mefloquine and losartan potassium
Article | Year |
---|---|
From the Food and Drug Administration.
Topics: Adenocarcinoma; Amidines; Anemia; Antimalarials; Clinical Trials as Topic; Colonic Neoplasms; Erythropoietin; Humans; Levamisole; Malaria; Mefloquine; Pentamidine; Pneumonia, Pneumocystis; Quinolines; Recombinant Proteins | 1989 |
1 other study(ies) available for mefloquine and losartan potassium
Article | Year |
---|---|
Serum concentrations of granulocyte-colony stimulating factor in complicated Plasmodium falciparum malaria.
Topics: Adolescent; Adult; Animals; Antimalarials; Artemisinins; Artesunate; Calcitonin; Calcitonin Gene-Related Peptide; Chemokine CCL4; Child; Enzyme-Linked Immunosorbent Assay; Erythrocytes; Erythropoietin; Female; Granulocyte-Macrophage Colony-Stimulating Factor; Humans; Macrophage Inflammatory Proteins; Malaria, Falciparum; Male; Mefloquine; Middle Aged; Nitrates; Plasmodium falciparum; Protein Precursors; Reference Values; Sesquiterpenes; Stem Cell Factor | 2000 |